報價延遲最少15分鐘:2026/01/07 18:51 EST
盤後時段
|
||||
|
5 
|
|
|
常規時段 (已結束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
5
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.12/-0.50
|
|
企業價值
353.51M
|
| 資產負債 |
|
每股賬面淨值
0.89
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
65.17M
|
|
每股收益
0.87
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing dataand generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil. |
